Kimi Iguchi
Director of Finance/CFO presso SAGE THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 29/02/2024
Profilo
Attualmente, Kimi E. Iguchi occupa la posizione di direttore finanziario e tesoriere presso SAGE Therapeutics, Inc. La signora Iguchi è anche nel consiglio di amministrazione di Disarm Therapeutics, Inc. In precedenza è stata vicepresidente finanziario di Cyberkinetics Neurotechnology Systems, Inc., direttore operativo della regione Nord America presso Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting presso Biogen, Inc. e direttore finanziario presso Biogen MA, Inc. (una filiale di Biogen, Inc.), Senior Director-Finance, Reporting & Analysis presso Millennium Pharmaceuticals, Inc. e Manager-Business Assurance presso PricewaterhouseCoopers LLP. La signora Iguchi si è laureata alla Drew University e ha conseguito un MBA alla Northeastern University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.14% | 13/02/2024 | 81 679 ( 0.14% ) | 2 M $ | 29/02/2024 |
Posizioni attive di Kimi Iguchi
Società | Posizione | Inizio |
---|---|---|
SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2013 |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 25/10/2018 |
Precedenti posizioni note di Kimi Iguchi
Società | Posizione | Fine |
---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/09/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Director of Finance/CFO | 31/05/2007 |
BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/1995 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Formazione di Kimi Iguchi
Drew University | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOGEN INC. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
Aziende private | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |